Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 22, 2024

Effects of GLP-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation

JACC: Clinical Electrophysiology

 

Additional Info

JACC: Clinical Electrophysiology
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation
JACC Clin Electrophysiol 2024 Aug 01;10(8)1848-1855, DI Satti, A Karius, JSK Chan, N Isakadze, R Yadav, K Garg, KN Aronis, JE Marine, R Berger, H Calkins, D Spragg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading